L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major

British Journal of Haematology

Volumn 76, Issue 4, 1990, Pages 550-553

  Toundury, Petrin ^a   Kontoghiorghes, George J ^a,b   Ridolfi‐Luuthy, Annette ^a   Hirt, Andreas ^a   Hoffbrand, A Victor ^a,b   Lottenbach, Anne Marie ^a   Sonderegger, Theo ^c   Wagner, Hans P ^a  

^a Department of Pediatrics ^*

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFERIPRONE;

ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; IRON CHELATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; CHILD; FEMALE; FERRITIN; HUMAN; IRON; IRON CHELATING AGENTS; MALE; PILOT PROJECTS; PYRIDONES; THALASSEMIA;

EID: 0025605569     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1990.tb07915.x     Document Type: Article

References (19)

1. Management of iron overload in the pediatric patient
2. Agranulocytosis and thrombocytopenia in patient with Blackfan‐Diamond anaemia during oral chelator trial
3. Results of long‐term subcutaneous desferrioxamine therapy
4. Dose response studies using desferrioxamine and orally active chelators in mice
5. Simple synthesis of the potent iron chelators 1‐alkyl‐3‐hydroxy‐2‐methylpyrid‐4‐ones
6. Effective chelation of iron in β thalassaemia with the oral chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one
7. 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one, an orally active chelator for treatment of iron overload
8. Iron chelation studies using desferrioxamine and the parenteral oral chelator 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one in normal and iron loaded rats
9. Prospects for effective and oral chelation in transfusional iron overload
10. Oral 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one for the treatment of transfusional iron overload. (Abstract)
11. Iron balance studies in thalassaemia major patients receiving oral 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one, (Abstract)
12. Prospects for effective oral iron chelation therapy in man with 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one and other α‐ketohydroxy‐pyridines
13. Safety of oral iron chelator L1
14. Desferrioxamine‐induced iron excretion in humans
15. The toxic effects of desferrioxamine
16. Animal toxicology of iron chelator L1
17. The development of iron chelating drugs